Country Analysis for the APAC region show that India's bioscience success story received a jolt in 2013 due to regulatory and pricing issues.
The sector grew only by 3 percent. Interestingly, India too had eight companies that crossed the $1 billion mark. In fact, India's two leading companies Sun Pharma and Dr Reddy's have touched the $2 billion mark for the first time.
India announced its plan to elevate its pharma industry to touch $100 billion by 2020.
USFDA deputed training personnel to Indian state, Gujarat, to enhance quality standards of drugs exported from the state.